Dear members, please see below call for comments. If you’re impacted by this call, please let me know at regulatory@bivda.org.uk.
Imidazole hydrobromide is used in optoelectrical components including LEDs. 1-methylimidazole acts as a solvent and catalyst in the production of pharmaceuticals, coatings, and polymers, as well as a curing agent for epoxy resins and a building block for ionic liquids and other specialty chemicals.
ECHA public consultations: call for comments
The Great Britain Mandatory Classification and Labelling (GB MCL) process includes the consideration of information gathered from public consultations, conducted by HSE or international bodies such as the European Chemicals Agency (ECHA).
ECHA has announced public consultations on the following proposals for harmonised classification and labelling (CLH):
Deadline: 5 December 2025
- flutolanil (ISO) (EC: -; CAS:6632-96-5). Pesticide active substance. All hazard classes open for commenting
Deadline: 19 December 2025
- imidazole hydrobromide (EC: 483-310-2; CAS: 101023-55-6). Chemical registered under REACH. Health hazard class open for commenting
- 1-methylimidazole (EC: 210-484-7; CAS: 616-47-7). Chemical registered under REACH. Health hazard classes open for commenting
Interested parties are invited to submit comments to the above consultations by the dates specified above. The comments will be published on ECHA’s website.
View the consultations on the ECHA website.
UK-based businesses with an interest in the proposal are strongly encouraged to share any relevant information.
Scientific and technical information should be submitted directly to ECHA using their commenting webform by the deadlines listed above. Comments will be published on ECHA’s website.
Further information
If your business is affected by the GB CLP Regulation, please also consider if you are likely to be affected by the classification and labelling proposals.
Let us know at an early stage if you anticipate any significant impacts or benefits.
Information on wider policy and impact considerations can be submitted to HSE at GBCLP.GBMCL@hse.gov.uk.
Under the GB CLP Regulation, HSE will consider published opinions of the Committee for Risk Assessment of ECHA (RAC) before publishing its own Agency Technical Reports and Agency Opinions, so any information you provide will be important in any final GB MCL decision.
More information on the new GB MCL system is available on the HSE website.
